|
Title
|
Published
|
Price
|
|
Freedonia Focus on Cancer Therapies
By: Freedonia Focus
This report discusses US demand for cancer therapies for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, types of cancer, diagnosis and screening, technology
|
more...
|
11/30/2009
|
$500.00
|
|
United States Type 2 Diabetes Market
By: Intellent
Intellent's new industry report focuses on the US type 2 diabetes market. This report provides valuable insight and access to the competitive information and analysis necessary to make decisions regarding the direction of the market
|
more...
Search inside this report
|
11/14/2009
|
$7,500.00
|
|
Snapshots Venezuela Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Venezuela Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Venezuelan pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots South Africa Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots South Africa Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the South African pharmaceutical
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
By: Datamonitor
Introduction
Courtesy of the patent cliff, the pharmaceutical industry is set for a dramatic slow down in revenue growth from 2011. Industry players are therefore looking to implement strategies which will cushion them against the
|
more...
|
11/12/2009
|
$7,600.00
|
|
Snapshots Poland Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Poland Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Polish pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots Hungary Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Hungary Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Hungarian pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots US Nasal Products 2009
By: Snapdata International Group
Snapdata's Snapshots US Nasal Products 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US nasal product
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots Denmark OTC Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Denmark OTC Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Danish OTC pharmaceutical
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots US OTC Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots US OTC Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US OTC pharmaceutical
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots Spain Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Spain Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Spanish pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots US Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Thailand Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
In BMI’s Pharmaceutical Environment Ratings (BER) table for Q110, Thailand slipped from ninth totenth position among the 15 key markets surveyed in the Asia Pacific region. Thailand’s growing andageing population represents a substantial commercial opportunity
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Poland Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
Poland is one of the highest value markets in Central and Eastern Europe (CEE) and as a result is adestination for almost all multinationals operating within the region. Poland’s pharmaceutical market hasshown consistently strong growth
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Argentina Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
The value of Argentina’s pharmaceutical market in 2008 was US$3.7bn. BMI’s updated forecasts see themarket reaching a value of US$6.12bn by 2014, representing a compound annual growth rate (CAGR) of12.68% in US dollar terms. With
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Kenya Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
BMI’s proprietary Drug Expenditure Forecast Model reveals that the Kenyan pharmaceutical market willreturn to a double-digit growth rate in 2009 (in local currency terms), after declining to single-digitgrowth the previous year. During 2008, OTC and
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Nigeria Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
The value of Nigeria’s pharmaceutical market in 2008 was NGN80.9bn (US$680mn). We forecast a12.8% year-on-year (y-o-y) growth in local currency during 2009, expecting that the market will grow bya compound annual growth rate (CAGR) of
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Company Financials: Bayer AG
By: Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet,
|
more...
|
11/10/2009
|
$75.00
|
|
Takeda Pipeline, Products, Performance, Potential
By: Espicom Healthcare Intelligence
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to
|
more...
Search inside this report
|
11/10/2009
|
$1,130.00
|
|
Merck & Co. Performance, Products, Pipeline and Potential
By: Espicom Healthcare Intelligence
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to
|
more...
Search inside this report
|
11/10/2009
|
$1,130.00
|
|
Australia Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
Australia’s pharmaceutical market is among the most developed in the Asia-Pacific region. Access tomedication is good across all sections of the population, with per-capita spending calculated at US$352 in2008. While not particularly high by Western
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Drug Price/Cost Debate: Coping with Escalating Pricing Pressures
By: Decision Resources
Introduction
Insinuations of profi teering were made against an H1N1 swine flu vaccine manufacturer in the summer of 2009.
As the swine flu epidemic began to take on serious proportions, public scrutiny in the United
|
more...
|
11/9/2009
|
$2,250.00
|
|
Chiropractor Offices
By: First Research, Inc.
The US chiropractic industry includes about 36,000 businesses and 60,000 licensed chiropractors with combined annual revenue of nearly $10 billion. No major companies dominate. The industry is highly fragmented: the top 50 chiropractor offices generate
|
more...
Search inside this report
|
11/9/2009
|
$129.00
|
|
Company Financials: Chattem, Inc.
By: Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet,
|
more...
|
11/9/2009
|
$75.00
|
|
Prostate Cancer Drug Discoveries: What the Future Holds
By: Espicom Healthcare Intelligence
Prostate cancer is the second leading cause of cancer in the US and the third most common cancer worldwide. More than two million men in the US suffer with prostate cancer. Find out more about
|
more...
Search inside this report
|
11/5/2009
|
$2,460.00
|
|
Title
|
Published
|
Price
|
(0 items)
